Skip to content

Loading Gait in Spatic Cerebral Palsy

Immediate Effects of a Single Treadmill Gait Training Session With Additional Loading on Kinematic Gait Parameters in Children With Spastic Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02010736
Acronym
SCP
Enrollment
20
Registered
2013-12-13
Start date
2012-09-30
Completion date
2012-11-30
Last updated
2013-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic Hemiplegic Cerebral Palsy

Keywords

Cerebral palsy, Gait, Weight Bearing, Rehabilitation

Brief summary

The purpose of this study is to observe the behavior of kinematic variables in children with spastic hemiparetic cerebral palsy (SHCP), immediately after treadmill gait training with ankle loading. The children underwent a single treadmill training session with ankle loading. The kinematic parameters were assessed in three phases: before training (PRE); immediately after training (POST); and 5 minutes after the end of training (FOLLOW UP). The investigators hypothesized that the treadmill gait training with additional lower limb loading would be a disturbance capable of modifying the locomotor strategy of children with SHCP, by the increase in kinematic parameters in the swing phase of gait.

Interventions

OTHERSingle treadmill gait training with additional loading

Sponsors

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Universidade Federal do Rio Grande do Norte
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* Spastic Hemiparetic Cerebral Palsy; * Being able to walk without an assistive device (levels I or II of the Gross Motor Function Classification System - GMFCS); * Not having undergone muscle lengthening surgery within the previous year; * Not having applied botulin toxin to the lower limbs or serial casting in the previous 6 months.

Exclusion criteria

* Inability to understand simple commands to perform the training and evaluation; * Inability to walk on the treadmill with or without load on the lower limbs; * Presence of any physical pain or discomfort during the course of training.

Design outcomes

Primary

MeasureTime frameDescription
Changes in kinematic gait parameters after treadmill trainning with ankles loadingImmediately after training with ankles loading (POST phase)Kinematic gait data were captured by Qualisys Track Manager 1.6.0.x - QTM software and exported to Visual3D processing software, to reconstruct the segments and create a biomechanical model. It was carried out in two stages: static and dynamic collection. The dynamic collection was performed while the children walked on the electric treadmill. The primary outcome measure was the following spatiotemporal variables at the POST phase: cadence (steps/min), stride length (m), paretic step length (m), stance time (%), swing time (%) paretic lower limb (PLL), double stance (%), symmetry ratio and stance/swing time ratio. With respect to angular variables, the following parameters was analysed: angular displacement (maximum flexion, maximum extension and range of motion) of the hip and knee were investigated (º).

Secondary

MeasureTime frameDescription
Changes in kinematic gait parameters after five minutes of restAfter five minutes of rest (FOLLOW UP phase)Kinematic gait data were captured by Qualisys Track Manager 1.6.0.x - QTM software and exported to Visual3D processing software, to reconstruct the segments and create a biomechanical model. It was carried out in two stages: static and dynamic collection. The dynamic collection was performed while the children walked on the electric treadmill. The secundary outcome measure was the same spatiotemporal and angular variables investigated at the POST phase although in this condition they was analysed at FOLLOW UP phase.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026